MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.transproceed.2008.09.017

Медицинская библиотека · Transplantation proceedings · 2008

Efficacy and safety of mycophenolate mofetil monotherapy in liver transplant patients with renal failure induced by calcineurin inhibitors.

Barrera Pulido L, Alamo Martínez J M, Pareja Ciuró F, Gómez Bravo M A, Serrano Díez-Canedo J, Bernal Bellido C, Suárez Artacho G, García González I, Pascasio Acevedo J M, Bernardos Rodríguez A

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To assess the efficacy and safety of mycophenolate mofetil (MMF) monotherapy in liver transplant recipients with renal failure secondary to the use of calcineurin inhibitors (CNIs).

MATERIALS AND

METHODS

Thirty-one patients on MMF monotherapy with creatinine levels >1.3 mg/dL, previously immunosuppressed with CNIs and MMF, were analyzed. Conversion was started in patients with no acute or chronic rejection episodes and stable liver chemistry. CNI doses were reduced by 25% every 2 to 3 months, or to 50% if the dose was lower than 1 mg/d of tacrolimus or 50 mg/d of cyclosporine. Different variables were recorded from the time that conversion to monotherapy was decided, on the discontinuation day of the calcineurin inhibitor, and during the follow-up.

RESULTS

Mean times from transplant to conversion ranged from 14 to 186 months. The minimum follow-up time in monotherapy was 12 months. Renal function improved at 6 months in 70% of cases and at 12 months in 69.6%. Patients with no renal function improvement maintained stable creatinine values. There were no rejection episodes, graft losses, or deaths. No leukopenia occurred, and triglyceride and uric acid values improved.

CONCLUSIONS

MMF monotherapy is a safe alternative in patients with posttransplant renal failure secondary to the use of CNIs. Renal function improvement was achieved in almost 70% of patients at 12 months, and creatinine values were maintained in all other patients. The risk of rejection due to the slow tapering of CNIs is minimum.

Для цитирования: Barrera Pulido L, Alamo Martínez J M, Pareja Ciuró F, Gómez Bravo M A, Serrano Díez-Canedo J, Bernal Bellido C, Suárez Artacho G, García González I, Pascasio Acevedo J M, Bernardos Rodríguez A. Efficacy and safety of mycophenolate mofetil monotherapy in liver transplant patients with renal failure induced by calcineurin inhibitors.. Transplantation proceedings. 2008. DOI: 10.1016/j.transproceed.2008.09.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.